Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
HLA DRB1 Antibody (SPM288), mFluor Violet 500 SE, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP311419MFV500
Description
HLA DRB1 Monoclonal antibody specifically detects HLA DRB1 in Human, Monkey, Mouse (Negative) samples. It is validated for Flow CytometrySpecifications
HLA DRB1 | |
Monoclonal | |
mFluor Violet 500 SE | |
50mM Sodium Borate | |
Mouse | |
Protein A or G purified | |
RUO | |
Primary | |
Human, Monkey, Mouse (Negative) | |
Purified |
Flow Cytometry | |
SPM288 | |
Flow Cytometry | |
Clone P2-beta-3, DR1, DR-1, DR12, DR-12, DR13, DR-13, DR14, DR-14, DR16, DR-16, DR4, DR-4, DR5, DR-5, DR7, DR-7, DR8, DR-8, DR9, DR-9, DRB1, DRw10, DRw11, DRw8, DW2.2/DR2.2, FLJ75017, FLJ76359, HLA class II antigen beta chain, HLA class II histocompatibility antigen, DR-1 beta chain, HLA-DR1B, HLA-DRB, HLA-DRB1*, HLA-DRB2, HLA-DR-beta 1, human leucocyte antigen DRB1, leucocyte antigen DR beta 1 chain, leucocyte antigen DRB1, lymphocyte antigen DRB1, major histocompatibility complex, class II, DR beta 1, MHC class II antigen DRB1*1, MHC class II antigen DRB1*10, MHC class II antigen DRB1*11, MHC class II antigen DRB1*12, MHC class II antigen DRB1*13, MHC class II antigen DRB1*14, MHC class II antigen DRB1*15, MHC class II antigen DRB1*16, MHC class II antigen DRB1*3, MHC class II antigen DRB1*4, MHC class II antigen DRB1*7, MHC class II antigen DRB1*8, MHC class II antigen DRB1*9, MHC class II antigen HLA-DR13, MHC class II HLA-DR beta 1 chain, MHC class II HLA-DR-beta cell surface gly | |
Activated human peripheral blood mononuclear cells | |
0.1 mL | |
Adaptive Immunity, Asthma, Cell Biology, Diabetes Research, Immunology | |
3123 | |
Store at 4C in the dark. | |
IgG2b κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction